Tetranectin Binds to the Kringle 1-4 Form of Angiostatin and Modifies Its Functional Activity

Journal of Biomedicine & Biotechnology
Tirsit MoguesKevan L. Hartshorn

Abstract

Tetranectin is a plasminogen kringle 4 domain-binding protein present in plasma and various tissue locations. Decreased plasma tetranectin or increased tetranectin in stroma of cancers correlates with cancer progression and adverse prognosis. A possible mechanism through which tetranectin could influence cancer progression is by altering activities of plasminogen or the plasminogen fragment, angiostatin. Tetranectin was found to bind to the kringle 1-4 form of angiostatin (AST $;{\text{K1-4}}$ ). In addition, tetranectin inhibited binding of plasminogen or AST $;{\text{K1-4}}$ to extracellular matrix (ECM) deposited by endothelial cells. Finally, tetranectin partially counteracted the ability of AST $;{\text{K1-4}}$ to inhibit proliferation of endothelial cells. This latter effect of tetranectin was specific for AST $;{\text{K1-4}}$ since it did not counteract the antiproliferative activities of the kringle 1-3 form of angiostatin (AST $;{\text{K1-3}}$ ) or endostatin. These findings suggest that tetranectin may modulate angiogenesis through interactions with AST.

Citations

Jan 23, 2010·Journal of Biosciences·Mee Lee LooiYasmin Anum Mohd Yusof
Nov 18, 2009·Biochemistry. Biokhimii︠a︡·R B AisinaS D Varfolomeyev
Dec 22, 2015·Journal of Psychiatric Research·M G GottschalkS Bahn
Jan 28, 2010·Clinica Chimica Acta; International Journal of Clinical Chemistry·Liang WangXuefeng Wang
Jan 27, 2007·Biomaterials·Claudia Fischbach, David J Mooney
Feb 24, 2006·Pediatric Diabetes·Christina Mylona-KarayanniElli F Kamper
Nov 23, 2010·Journal of Clinical Laboratory Analysis·Ioannis PanagiotopoulosElli F Kamper
Jul 23, 2013·Journal of Cardiothoracic Surgery·Isabel PreeshagulK Stephen Suh
Feb 3, 2005·Molecular & Cellular Proteomics : MCP·Timothy D VeenstraRichard S Morrison
Oct 20, 2010·International Journal of Molecular Sciences·Martha E Arellano-GarciaShen Hu
Sep 23, 2006·Chembiochem : a European Journal of Chemical Biology·Fabio GrandiBruno Samorì
Apr 14, 2007·Virchows Archiv : an International Journal of Pathology·A BrunnerA Tzankov
Apr 22, 2015·Bioorganicheskaia khimiia·R B Aĭsina, L I Mukhametova

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.